• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Aromatase inhibitor withdrawal response in metastatic breast cancer.

作者信息

Cigler Tessa, Goss Paul E

机构信息

Massachusetts General Hospital, Boston, MA, USA.

出版信息

J Clin Oncol. 2006 Apr 20;24(12):1955-6. doi: 10.1200/JCO.2005.03.4108.

DOI:10.1200/JCO.2005.03.4108
PMID:16622274
Abstract
摘要

相似文献

1
Aromatase inhibitor withdrawal response in metastatic breast cancer.
J Clin Oncol. 2006 Apr 20;24(12):1955-6. doi: 10.1200/JCO.2005.03.4108.
2
[A case of a premenopausal woman with advanced breast cancer treated with aromatization inhibition in combination with luteinizing hormone-releasing hormone agonist].[一例绝经前晚期乳腺癌患者采用芳香化抑制联合促黄体生成素释放激素激动剂治疗的病例]
Gan To Kagaku Ryoho. 1997 Aug;24(10):1327-30.
3
[A case of premenopausal metastatic breast cancer treated with goserelin plus aromatase inhibitor as second-line endocrine therapy].一例使用戈舍瑞林联合芳香化酶抑制剂作为二线内分泌治疗的绝经前转移性乳腺癌病例
Gan To Kagaku Ryoho. 2009 Nov;36(11):1905-6.
4
Failure of goserelin ovarian ablation in premenopausal women with breast cancer: two case reports.戈舍瑞林对绝经前乳腺癌女性卵巢去势失败：两例病例报告
Gynecol Oncol. 2000 Jan;76(1):126-7. doi: 10.1006/gyno.1999.5641.
5
Short term results from GHRH analogue use in pre-menopausal breast cancer in Korea.韩国绝经前乳腺癌患者使用生长激素释放激素类似物的短期结果。
Eur J Surg Oncol. 2009 Sep;35(9):936-41. doi: 10.1016/j.ejso.2009.01.016. Epub 2009 Mar 6.
6
Hormonal therapy for advanced breast cancer.晚期乳腺癌的激素治疗
Hematol Oncol Clin North Am. 2007 Apr;21(2):273-91. doi: 10.1016/j.hoc.2007.03.007.
7
Combined ovarian ablation and aromatase inhibition as first-line therapy for hormone receptor-positive metastatic breast cancer in premenopausal women: report of three cases.联合卵巢去势与芳香化酶抑制作为绝经前激素受体阳性转移性乳腺癌的一线治疗：三例报告
Anticancer Drugs. 2006 Sep;17(8):999-1002. doi: 10.1097/01.cad.0000224456.28898.37.
8
[Basic Consensus on endocrinotherapy for breast cancer].[乳腺癌内分泌治疗基本共识]
Zhonghua Zhong Liu Za Zhi. 2006 Mar;28(3):238-9.
9
[Effectiveness of LH-RH agonist for bone metastases of breast cancer--report of a case].[促黄体生成素释放激素激动剂对乳腺癌骨转移的疗效——1例报告]
Gan To Kagaku Ryoho. 1996 May;23(6):787-90.
10
CMF versus goserelin as adjuvant therapy for node-negative, hormone-receptor-positive breast cancer in premenopausal patients: a randomised trial (GABG trial IV-A-93).CMF方案与戈舍瑞林作为绝经前、淋巴结阴性、激素受体阳性乳腺癌辅助治疗的比较：一项随机试验（GABG试验IV-A-93）
Eur J Cancer. 2006 Aug;42(12):1780-8. doi: 10.1016/j.ejca.2006.04.006. Epub 2006 Jun 12.

引用本文的文献

1
Drug withdrawal in women with progressive metastatic breast cancer while on aromatase inhibitor therapy.接受芳香化酶抑制剂治疗的晚期转移性乳腺癌女性患者的药物撤药情况。
Br J Cancer. 2014 Nov 25;111(11):2046-50. doi: 10.1038/bjc.2014.502. Epub 2014 Sep 18.
2
Endocrine-responsive breast cancer: a 28-year Odyssey.内分泌反应性乳腺癌：28年的探索历程。
Ecancermedicalscience. 2011;5:237. doi: 10.3332/ecancer.2011.237. Epub 2011 Dec 1.
3
Dual IGF-1R/InsR inhibitor BMS-754807 synergizes with hormonal agents in treatment of estrogen-dependent breast cancer.
双 IGF-1R/InsR 抑制剂 BMS-754807 与激素药物联合治疗雌激素依赖性乳腺癌具有协同作用。
Cancer Res. 2011 Dec 15;71(24):7597-607. doi: 10.1158/0008-5472.CAN-11-1080. Epub 2011 Oct 31.